53 completed, 8 recruiting, 6 unknown, 4 not yet recruiting. 26 Not applicable, 15 Phase 1, 11 Phase 2, 7 Phase 4, 6 Phase 3.
Follow Human Immunodeficiency Virus (HIV): new trials by email Literature Review of Human Immunodeficiency Virus (HIV) trials Research Report on Human Immunodeficiency Virus (HIV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States Qualitative interviews, Focus groups - Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV) | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 3500 | 2026-11-10 | 2026-10-20 | |
| Psilocybin Therapy for Methamphetamine Use Disorder and HIV Psilocybin 5 mg, Psilocybin 25 mg, Motivational Support - Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV) | Phase 2 | Not yet recruiting | Nicky Mehtani, MD, MPH | 30 | 2026-11-01 | 2026-08-11 |
| A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019) MK-8527, Rifampin - Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis | Phase 1 | Not yet recruiting | Merck Sharp & Dohme LLC | 14 | 2026-09-01 | 2026-08-03 |
| Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV Tirzepatide - Human Immunodeficiency Virus (HIV), Metabolic Dysfunction Associated Steatotic Liver Disease | Phase 4 | Enrolling by invitation | National Taiwan University Clinical Trial Center | 60 | 2026-06-25 | 2026-07-20 |
| Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV HPV DNA Testing (Abbott Alinity m HPV Assay), Visual Inspection with Acetic Acid, Cervical Histology (Biopsy Procedures) - Human Papillomavirus (HPV), HPV Associated Cancers | Not applicable | Not yet recruiting | University of California, San Diego | 750 | 2026-06-01 | 2026-05-08 |
| ComBaCaL HIV Prevention TwiCs CoPrev model, Referral to the nearest responsible health facility - Human Immunodeficiency Virus (HIV) | Not applicable | Withdrawn | University Hospital, Basel, Switzerland | 2026-06-01 | 2026-09-16 | |
| The Trans-Led Care Study The TLC Program - Substance Abuse, Substance Addiction | Not applicable | Recruiting | Illinois Institute of Technology | 124 | 2026-04-14 | 2026-07-15 |
| The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV Chiropractic Care - Human Immunodeficiency Virus (HIV) | Not applicable | Active not recruiting | Tyson Perez, DC, PhD | 10 | 2026-04-11 | 2026-08-18 |
| HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics HTS counselor-led PrEP care model - Human Immunodeficiency Virus (HIV), HIV Pre-exposure Prophylaxis | Not applicable | Recruiting | University of Washington | 30000 | 2025-12-01 | 2026-06-18 |
| A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010) MK-8527, Emtricitabine/tenofovir disoproxil (FTC/TDF), Placebo matched to MK-8527 - Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis | Phase 3 | Recruiting | Merck Sharp & Dohme LLC | 4580 | 2025-11-10 | 2026-10-20 |
| Voluntary HIV Screening in the General Population in France data collections - Human Immunodeficiency Virus (HIV) | Recruiting | Université de Reims Champagne-Ardenne | 1000 | 2025-10-07 | 2026-02-18 | |
| Reducing Systemic Inflammation in People on Antiretroviral Therapy Fostemsavir - Human Immunodeficiency Virus (HIV), Cardiovascular Risk Factor | Phase 2 | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 150 | 2025-09-30 | 2025-11-19 |
| Quitting Matters Human Immunodeficiency Virus Hybrid Trial Learn to Quit-HIV (LTQ-H) App, QuitStart - Tobacco, Tobacco Abstinence | Not applicable | Recruiting | Wake Forest University Health Sciences | 314 | 2025-08-18 | 2026-09-30 |
| A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) MK-8527, FTC/TDF, Placebo to MK-8527 - Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis | Phase 3 | Active not recruiting | Merck Sharp & Dohme LLC | 4390 | 2025-07-31 | 2026-09-18 |
| Vitamin D3 Supplementation in Patients With HIV: Effects on Interleukin-6 Levels and CD4 Counts Vitamin D3, Antiretroviral (ARV) medications - Human Immunodeficiency Virus (HIV) | Not applicable | Completed | Universitas Sebelas Maret | 20 | 2025-06-01 | 2026-07-15 |
| Project neuroARTEMIS ARTEMIS, Contingency management for Antiretroviral (ARV) adherence - Stimulant Use, Human Immunodeficiency Virus (HIV) | Not applicable | Recruiting | Wake Forest University Health Sciences | 189 | 2025-04-29 | 2026-09-03 |
| Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care Motivational Interviewing (MI) Counseling, Peer Mentoring, Skills-based Text Messaging - Human Immunodeficiency Virus (HIV), Smoking Cessation | Phase 4 | Recruiting | New York University | 500 | 2024-10-18 | 2026-04-13 |
| Persuasive Health Communication Intervention for HIV/HCV Video Format with Captions, Video Format without Captions, Health Educator - Human Immunodeficiency Virus (HIV), Hepatitis C (HCV) | Not applicable | Completed | University of South Florida | 2000 | 2023-12-04 | 2026-10-13 |
| A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE) MK-8527, LNG/EE - Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis | Phase 1 | Completed | Merck Sharp & Dohme LLC | 14 | 2023-08-14 | 2025-01-20 |
| Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk Health kiosk - Opioid-Related Disorders, Hepatitis C (HCV) | Not applicable | Active not recruiting | April M Young | 752 | 2023-03-06 | 2026-08-18 |
Showing 20 of 82. Sign in to see all of them.
Acquired Immunodeficiency Syndrome (82) · Sexually Transmitted Diseases (7) · Substance-Related Disorders (5) · Hepatitis C (3) · Tuberculosis (3) · Coitus (2) · HIV Infections (2) · Hepatitis C, Chronic (2) · Smoking Cessation (2) · Social Stigma (2) · Unsafe Sex (2) · Uterine Cervical Dysplasia (2) · Uterine Cervical Neoplasms (2) · Alcohol Drinking (1) · Amphetamine-Related Disorders (1)
Blood-Borne Infections (82) · Communicable Diseases (82) · Genital Diseases (82) · Immune System Diseases (82) · Immunologic Deficiency Syndromes (82) · Infections (82) · Lentivirus Infections (82) · RNA Virus Infections (82) · Retroviridae Infections (82) · Sexually Transmitted Diseases, Viral (82) · Slow Virus Diseases (82) · Urogenital Diseases (82) · Virus Diseases (82) · HIV Infections (80) · Sexually Transmitted Diseases (75)
Darunavir (3) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (3) · Ritonavir (3) · 3BNC117 antibody (2) · Anti-Retroviral Agents (2) · Antibodies, Monoclonal (2) · Cholecalciferol (2) · Cyclophosphamide (2) · Emtricitabine (2) · Maraviroc (2) · Motivational Interviewing (2) · Tenofovir (2) · Zidovudine (2) · budigalimab (2) · efavirenz (2)
Columbia University (6) · Merck Sharp & Dohme LLC (5) · University of Colorado, Denver (4) · AbbVie (3) · Johns Hopkins University (2) · Karolinska Institutet (2) · RTI International (2) · Rockefeller University (2) · University of Florida (2) · University of Pennsylvania (2) · Wake Forest University Health Sciences (2) · April M Young (1) · Bristol-Myers Squibb (1) · Bruce Brew (1) · Caribbean Health Research Council (1)
United States (42) · South Africa (6) · Australia (4) · Canada (4) · Lesotho (4) · Puerto Rico (4) · France (3) · Germany (3) · Kenya (3) · Vietnam (3) · Ethiopia (2) · Ghana (2) · Indonesia (2) · Spain (2) · Switzerland (2)
Wafaa M El-Sadr, MD/MPH (3) · Batya Elul, PhD, MSc (2) · Bruce J Brew, MBBS, PhD (2) · Felicia Browne, ScD (2) · Marina Caskey, MD (2) · Adam W Carrico, PhD (1) · Adriana Weinberg, MD (1) · Anak Agung Sagung Sawitri, DR (1) · Anandi Sheth, MD, MSc (1) · April M Young, PhD (1)
PMID 20146627, PMID 20735258, PMID 22122590, PMID 22293363, PMID 23539185, PMID 24516580, PMID 25040114, PMID 25428563, PMID 25585528, PMID 25723985, PMID 25723986, PMID 25872747, PMID 26825032, PMID 27891160, PMID 27986077, PMID 28883928, PMID 29879143, PMID 30081868, PMID 30184165, PMID 30907323, PMID 31121013, PMID 31121015, PMID 31366394, PMID 31562059, PMID 31611038, PMID 31651098, PMID 31923277, PMID 32404389, PMID 32838558, PMID 33125080, PMID 33191765, PMID 33336698, PMID 33404004, PMID 33571163, PMID 33616229, PMID 33852720, PMID 34006921, PMID 34287217, PMID 34769920, PMID 34896961, PMID 35532978, PMID 35544074, PMID 35587247, PMID 35783486, PMID 37233720, PMID 37495904, PMID 37615878, PMID 37980472, PMID 38141637, PMID 38431295
R01AI083038 (3), R01MH089831 (2), U24CA275417 (2), 1DP2DA066200 (1), 2014 (1), 2019 (1), 2025 (1), R00DA055508 (1), R01AA022067 (1), R01CA285331 (1), R01DA055533 (1), R01DA055872 (1), R01DA061952 (1), R01HD071779 (1), R01MD004075 (1)